Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
PrivateLast Round
Series C
Extension
Apr 9, 2024
Total Funding Raised
$43.44M
Company Overview
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. is a biotechnology company that develops innovative diagnostic and therapeutic radiopharmaceuticals for oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Imaging, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. Comparables
Compare Suzhou SmartNuclide Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 82% | |
| Sanofi | 78% | |
| Ablaze Pharmaceuticals | 78% | |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 9, 2024 | ||||
| Series C | Jul 7, 2021 | ||||
| Series B | Apr 23, 2020 | ||||
| Series A Extension | Nov 1, 2018 | ||||
| Series A | Mar 22, 2018 | ||||
Angel | Mar 1, 2016 |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agricultural Bank of China International | Series C |
| Longmen Capital | Series A Extension |
| Oriza Holdings | Series C Extension |
| Peppermint Venture Partners | Angel |
| Jiuyo Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2024
$14M round led by Oriza Holdings
- Jul 7, 2021
$15.5M round with Agricultural Bank of China International and CIB Guoxin.
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Suzhou SmartNuclide Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.